Skip to content

Insider · CIK 0001732986

Angela Justice

officer

Files at TCRR (TCR2 THERAPEUTICS INC.). First filing Dec 5, 2022, latest Dec 13, 2022.

In brief

Angela Justice files SEC Form 4 as officer at TCRR (TCR2 THERAPEUTICS INC.). Since Dec 5, 2022, Angela Justice has reported 0 open-market buys worth $0 and 4 open-market sells worth $25k, the latest filed on Dec 13, 2022.

A track record needs three past buys with six months of prices behind them; Angela Justice has 0, so none is measured yet.

The newest scored trade: sold $9,448 of TCRR on Dec 9, 2022, filed Dec 13, 2022, scored 15 (weak), under a 10b5-1 plan.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 4
$0 bought, $25k sold

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
15Weak
TCRRsell 410b5-1
TCR2 THERAPEUTICS INC.
$9,448
8,620 shares
-15%-
10Weak
TCRRsell 410b5-1
TCR2 THERAPEUTICS INC.
$6,301
4,968 shares
-8%-
10Weak
TCRRsell 410b5-1
TCR2 THERAPEUTICS INC.
$6,310
4,663 shares
-7%-
0Weak
TCRRsell 410b5-1
TCR2 THERAPEUTICS INC.
$3,162
2,273 shares
-3%-

Transactions

Every row this insider has filed, 33 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Jun 1, 2023TCRR
TCR2 THERAPEUTICS INC.
DDisposition to issuer
Common Stock
-48,745--0Jun 1, 2023
Jun 1, 2023TCRR
TCR2 THERAPEUTICS INC.
DDisposition to issuer
Stock Option (Right to Buy)derivative
-78,499$0.00$00Jun 1, 2023
Jun 1, 2023TCRR
TCR2 THERAPEUTICS INC.
DDisposition to issuer
Stock Option (Right to Buy)derivative
-76,500$0.00$00Jun 1, 2023
Jun 1, 2023TCRR
TCR2 THERAPEUTICS INC.
DDisposition to issuer
Restricted Stock Unitderivative
-13,083$0.00$00Jun 1, 2023
Jun 1, 2023TCRR
TCR2 THERAPEUTICS INC.
DDisposition to issuer
Restricted Stock Unitderivative
-13,527$0.00$00Jun 1, 2023
Jun 1, 2023TCRR
TCR2 THERAPEUTICS INC.
DDisposition to issuer
Restricted Stock Unitderivative
-1,050$0.00$00Jun 1, 2023
Jun 1, 2023TCRR
TCR2 THERAPEUTICS INC.
DDisposition to issuer
Restricted Stock Unitderivative
-6,336$0.00$00Jun 1, 2023
Dec 15, 2022TCRR
TCR2 THERAPEUTICS INC.
AGrant or award
Stock Option (Right to Buy)derivative
+78,499$0.00$078,499Dec 19, 2022
Dec 15, 2022TCRR
TCR2 THERAPEUTICS INC.
AGrant or award
Restricted Stock Unitderivative
+13,083$0.00$013,083Dec 19, 2022
Dec 9, 2022TCRR
TCR2 THERAPEUTICS INC.
SOpen-market sale
Common Stock10b5-1
-2,792$1.13$3,14954,573Dec 13, 2022
Dec 12, 2022TCRR
TCR2 THERAPEUTICS INC.
SOpen-market sale
Common Stock10b5-1
-2,865$1.10$3,14951,708Dec 13, 2022
Dec 12, 2022TCRR
TCR2 THERAPEUTICS INC.
SOpen-market sale
Common Stock10b5-1
-2,963$1.06$3,15048,745Dec 13, 2022
Dec 7, 2022TCRR
TCR2 THERAPEUTICS INC.
SOpen-market sale
Common Stock10b5-1
-2,457$1.28$3,15059,876Dec 9, 2022
Dec 8, 2022TCRR
TCR2 THERAPEUTICS INC.
SOpen-market sale
Common Stock10b5-1
-2,511$1.26$3,15157,365Dec 9, 2022
Dec 5, 2022TCRR
TCR2 THERAPEUTICS INC.
SOpen-market sale
Common Stock10b5-1
-2,302$1.37$3,16164,694Dec 7, 2022
Dec 6, 2022TCRR
TCR2 THERAPEUTICS INC.
SOpen-market sale
Common Stock10b5-1
-2,361$1.33$3,15062,333Dec 7, 2022
Dec 1, 2022TCRR
TCR2 THERAPEUTICS INC.
MOption exercise
Common Stock
+59,576--69,269Dec 5, 2022
Dec 2, 2022TCRR
TCR2 THERAPEUTICS INC.
SOpen-market sale
Common Stock10b5-1
-2,273$1.39$3,16266,996Dec 5, 2022
Dec 1, 2022TCRR
TCR2 THERAPEUTICS INC.
MOption exercise
Restricted Stock Unitderivative
+50,889$0.00$013,527Dec 5, 2022
Dec 1, 2022TCRR
TCR2 THERAPEUTICS INC.
MOption exercise
Restricted Stock Unitderivative
+2,840$0.00$01,050Dec 5, 2022
Dec 1, 2022TCRR
TCR2 THERAPEUTICS INC.
MOption exercise
Restricted Stock Unitderivative
+5,847$0.00$06,336Dec 5, 2022
Nov 17, 2022TCRR
TCR2 THERAPEUTICS INC.
DDisposition to issuer
Stock Option (right to buy)derivative
-16,398$0.00$00Nov 18, 2022
Nov 17, 2022TCRR
TCR2 THERAPEUTICS INC.
AGrant or award
Restricted Stock Unit (right to buy)derivative
+5,466$0.00$05,466Nov 18, 2022
Nov 17, 2022TCRR
TCR2 THERAPEUTICS INC.
DDisposition to issuer
Stock Option (right to buy)derivative
-176,850$0.00$00Nov 18, 2022
Nov 17, 2022TCRR
TCR2 THERAPEUTICS INC.
AGrant or award
Restricted Stock Unit (right to buy)derivative
+58,950$0.00$058,950Nov 18, 2022
Nov 17, 2022TCRR
TCR2 THERAPEUTICS INC.
DDisposition to issuer
Stock Option (right to buy)derivative
-3,791$0.00$00Nov 18, 2022
Nov 17, 2022TCRR
TCR2 THERAPEUTICS INC.
AGrant or award
Restricted Stock Unit (right to buy)derivative
+1,264$0.00$01,264Nov 18, 2022
Nov 17, 2022TCRR
TCR2 THERAPEUTICS INC.
DDisposition to issuer
Stock Option (right to buy)derivative
-7,876$0.00$00Nov 18, 2022
Nov 17, 2022TCRR
TCR2 THERAPEUTICS INC.
AGrant or award
Restricted Stock Unit (right to buy)derivative
+2,626$0.00$02,626Nov 18, 2022
Nov 17, 2022TCRR
TCR2 THERAPEUTICS INC.
DDisposition to issuer
Stock Option (right to buy)derivative
-4,414$0.00$00Nov 18, 2022
Nov 17, 2022TCRR
TCR2 THERAPEUTICS INC.
AGrant or award
Restricted Stock Unit (right to buy)derivative
+803$0.00$0803Nov 18, 2022
Nov 17, 2022TCRR
TCR2 THERAPEUTICS INC.
DDisposition to issuer
Stock Option (right to buy)derivative
-62,586$0.00$00Nov 18, 2022
Nov 17, 2022TCRR
TCR2 THERAPEUTICS INC.
AGrant or award
Restricted Stock Unit (right to buy)derivative
+11,380$0.00$011,380Nov 18, 2022

Questions about Angela Justice

Answered from the filings on this page, as of the latest one.

Is Angela Justice buying or selling?

Not in the last 12 months. Angela Justice's latest open-market trade on SEC Form 4 was sold $9,448 of TCRR on Dec 9, 2022.

How did Angela Justice's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Angela Justice has 0.

Where does Angela Justice file Form 4?

Angela Justice has filed Form 4 at TCRR (TCR2 THERAPEUTICS INC.) as Chief People Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Angela Justice: insider trades and track record | InsiderTell